The Scientist

» FDA and cell & molecular biology

Most Recent

image: Sperm Shadows

Sperm Shadows

By | January 1, 2013

Tracking the shadows cast by sperm reveals their precise 3-D movements.

1 Comment

image: Evolution by Splicing

Evolution by Splicing

By | December 20, 2012

Comparing gene transcripts from different species reveals surprising splicing diversity.

1 Comment

image: Bones Get in Her Eyes

Bones Get in Her Eyes

By | December 20, 2012

After undergoing untested cosmetic surgery that uses stem cells to rejuvenate skin, a woman grew bone fragments in the flesh around one of her eyes.

2 Comments

image: Cancer More Diverse than Its Genetics

Cancer More Diverse than Its Genetics

By | December 13, 2012

Tumor cells can exhibit different behaviors despite being genetically indistinguishable.

4 Comments

image: Drug Approvals Up

Drug Approvals Up

By | December 7, 2012

The total number of new drugs approved this year ties last year for the highest since 2004, suggesting that the pharmaceutical industry is recovering.  

0 Comments

image: Detailing Color Vision

Detailing Color Vision

By | December 6, 2012

Scientists engineer a spectrum of artificial pigments to understand how animals see in color.

1 Comment

image: Hurry Up, FDA

Hurry Up, FDA

By | December 6, 2012

The US Food and Drug Administration is taking steps to get new devices on the market sooner—and antibiotics may be next.

0 Comments

image: Call for Conflict Hub

Call for Conflict Hub

By | December 3, 2012

Biomedical groups propose a simplified system for the disclosure of potential conflicts of interests.

0 Comments

image: Fat's Immune Sentinels

Fat's Immune Sentinels

By | December 1, 2012

Certain immune cells keep adipose tissue in check by helping to define normal and abnormal physiological states.

0 Comments

image: How Plants Feel

How Plants Feel

By | December 1, 2012

A hormone called jasmonate mediates plants' responses to touch and can boost defenses against pests.

1 Comment

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS